日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

2025年泌尿系统晚期肿瘤共识会议(AUC3):肾细胞癌和泌尿系统肿瘤治疗的专家共识

McKay, Rana R; Pal, Sumanta; Xie, Wanling; Aggen, David; Albiges, Laurence; Apolo, Andrea; Atkins, Michael B; Bangs, Rick; Beckermann, Kathryn E; Bellmunt, Joaquim; Berg, Stephanie A; Bilen, Mehmet A; Braun, David; Carlo, Maria I; Efstathiou, Jason; Galsky, Matthew; Grivas, Petros; Gupta, Shilpa; Haas, Naomi; Hakimi, A Ari; Hammers, Hans; Heng, Daniel Y C; Hirsch, Michelle; Iyer, Gopakumar; Jonasch, Eric; Koshkin, Vadim S; Kryvenko, Oleksandr; Lewis, Bryan; Li, Roger; Matin, Surena; Maughan, Benjamin; McDermott, David F; McGregor, Bradley; Meeks, Joshua; Milowsky, Matthew; Motzer, Robert; Necchi, Andrea; Petrylak, Dan; Porten, Sima; Powles, Thomas; Rini, Brian; Shuch, Brian; Siefker-Radtke, Arlene; Sonpavde, Guru; Sridhar, S Srikala; Suarez, Cristina; Tang, Chad; Tripathi, Abhishek; Van Der Heijden, Michiel S; Voss, Martin; Xu, Wenxin; Zhang, Tian; Rosenberg, Jonathan; Choueiri, Toni K

Targeting of HIF2-driven cachexia in kidney cancer.

针对肾癌中由HIF2驱动的恶病质的靶向治疗。

Abu-Remaileh Muhannad, Stransky Laura A, Bhalerao Nikita, Shirole Nitin H, Jiang Qinqin, Saad Eddy, Machaalani Marc, Vigeant Sean M, Woldemichael Hilina, Xu Charles, Lu Jing, Wei Hairong, Liu Zhihong, Sun William, Enomoto Kei, Choueiri Toni K, Pitarresi Jason R, Carr Steven A, Udeshi Namrata D, Kaelin William G Jr

Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma.

无细胞DNA表观基因组分析能够对易位性肾细胞癌进行无创检测和监测。

Garinet Simon, Semaan Karl, Li Jiao, Zhang Ze, Konda Prathyusha, Sadagopan Ananthan, Canniff John, Phillips Noa, Klega Kelly, Pandey Medha, Savignano Hunter, Davidsohn Matthew P, Lyons Kevin, Medda Alessandro, Khanna Prateek, Achom Mingkee, Fortunato Brad J, Nawfal Rashad, El Hajj Chehade Razane, O'Toole Jillian, Horst Jack, Freeman Dory, Trowbridge Rachel, Chau Cindy H, Figg William D, Berchuck Jacob E, Crompton Brian D, Seo Ji-Heui, Choueiri Toni K, Freedman Matthew L, Baca Sylvan C, Viswanathan Srinivas R

Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma

分区总生存期:CheckMate 9ER 研究中对晚期肾细胞癌一线治疗方案(纳武利尤单抗联合卡博替尼与舒尼替尼)4 年生存状态的综合分析

Viray, Hollis; M Mantia, Charlene; Jegede, Opeyemi A; Atkins, Michael B; Rosenblatt, Lisa; Choueiri, Toni K; McDermott, David F; Regan, Meredith M

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0

癌症免疫治疗学会 (SITC) 肾细胞癌免疫治疗临床实践指南,第 3.0 版

McKay, Rana R; Ajmera, Archana; Atkins, Michael B; Barata, Pedro C; Bergerot, Cristiane; Bukavina, Laura; Choueiri, Toni K; Desai, Arpita; Hakimi, A Ari; Poteat, Susan; Powles, Thomas; Rini, Brian I; Shuch, Brian; Signoretti, Sabina; Siva, Shankar; Xu, Wenxin; Yip, Wesley; Zhang, Tian; Pal, Sumanta K

Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2

对伴有 Merlin 蛋白缺乏和 NF2 双等位基因缺失的肾细胞癌进行综合临床和分子评估

Yekedüz, Emre; Bian, Weiwei; Siegmund, Stephanie E; Machaalani, Marc; El Masri, Jad; Saleh, Mustafa; Saad, Eddy; Ascione, Liliana; El Hajj Chehade, Razane; Steiner, Clara; Barrios, Pablo Moura; Berg, Stephanie A; McGregor, Bradley; Mantia, Charlene; Ravi, Praful; Xu, Wenxin; Hirsch, Michelle S; Choueiri, Toni K; Serzan, Michael

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma

转移性肾细胞癌中IMDC风险组极佳预后的临床和分子验证

Zarba, Martin; Saad, Eddy; Semaan, Karl; El Zarif, Talal; Ferrier, Evan; Wells, Connor; El Hajj Chehade, Razane; Basappa, Naveen S; Ebrahimi, Hedyeh; Huseni, Mahrukh; Banchereau, Romain; McKay, Rana R; Wood, Lori; Beuselinck, Benoit; Suárez, Cristina; Takemura, Kosuke; Lalani, Aly-Khan A; Li, Haoran; Spain, Lavinia Anne; Templeton, Arnoud J; Powles, Thomas B; Bjarnason, Georg A; de Velasco, Guillermo; Choueiri, Toni K; Heng, Daniel Y C

Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 Study

KEYNOTE-564 III期研究东亚亚组中肾细胞癌辅助治疗帕博利珠单抗与安慰剂的比较

Park, Se Hoon; Chang, Yen-Hwa; Lee, Jae Lyun; Choueiri, Toni K; Kimura, Go; Chung, Jinsoo; Masumori, Naoya; Nishimura, Kazuo; Kato, Minoru; Kato, Haruaki; Numakura, Kazuyuki; Chang, Chao-Hsiang; Anai, Satoshi; Tsunemori, Hiroyuki; Chen, Chung-Hsin; Lin, Jianxin; Elfiky, Aymen; Burgents, Joseph E; Kitamura, Hiroshi

Integrated inference of cancer gene expression from cell-free plasma chromatin.

从无细胞血浆染色质中综合推断癌症基因表达。

Gulati Gunsagar S, Vasseur Damien, Nawfal Rashad, Sotudian Shahabeddin, Semaan Karl, Eid Marc, Seo Ji-Heui, Phillips Noa, Canniff John J, Savignano Hunter, Chhetri Surya B, Jin Zhenjie, Ou Yukun, Bani Mohamed-Amine, Mary Lee Gwo-Shu, Trowbridge Rachel, Epstein Ilana B, Rickards Gabriella, Cordeiro Paulo Roberto Da Silva, Zhang Ze, Chehade Razane El Hajj, James Brady, Massard Christophe, Italiano Antoine, Hollebecque Antoine, Soria Jean-Charles, André Fabrice, Badoual Cécile, Bellmunt Joaquim, Singh Harshabad, Aguirre Andrew J, Wolpin Brian M, Choueiri Toni K, Baca Sylvan C, Freedman Matthew L

AXL signaling in cancer: from molecular insights to targeted therapies

AXL信号通路在癌症中的作用:从分子机制到靶向治疗

Yadav, Monika; Sharma, Akansha; Patne, Ketki; Tabasum, Saba; Suryavanshi, Jyoti; Rawat, Laxminarayan; Machaalani, Marc; Eid, Marc; Singh, Rana P; Choueiri, Toni K; Pal, Soumitro; Sabarwal, Akash